ArticleThe AAPS journal2022

Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy.

Susan C Irvin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.